Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/ kidney injury molecule (Kim-1) signaling pathway

Loading...
Thumbnail Image

Authors

Oyagbemi, Ademola Adetokunbo
Omobowale, Temidayo Olutayo
Adejumobi, Olumuyiwa Abiola
Owolabi, Abiodun Mary
Ogunpolu, Blessing Seun
Falayi, Olufunke Olubunmi
Hassan, Fasilat Oluwakemi
Ogunmiluyi, Iyanuoluwa Omolola
Asenuga, Ebunoluwa Racheal
Ola-Davies, Olufunke Eunice

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

Please read abstract in the article.

Description

Keywords

Hypertension (HTN), Oxidative stress, Naringenin, Novel-antihypertensive agent, SDG-03: Good health and well-being, Antihypertensive power, Mineralocorticoid receptor (MCR), Angiotensin converting enzyme (ACE), Kidney injury molecule (Kim-1)

Sustainable Development Goals

Citation

Oyagbemi, A.A., Omobowale, T.O., Adejumobi, O.A. et al. 2020, 'Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/ kidney injury molecule (Kim-1) signaling pathway', European Journal of Pharmacology, vol. 880, art. 173142, pp. 1-13, doi : 10.1016/j.ejphar.2020.173142.